؉ CD25 ؉ T cells were generated from autoreactive T cells without negative selection. However, it is unclear whether, in general, positive selection and negative selection of autoreactive T cells are mutually exclusive processes in the thymus. To investigate the ontogeny of CD4 ؉ CD25 ؉ regulatory T cells, neo-autoantigen-bearing transgenic mice expressing chicken egg OVA systemically in the nuclei (Ld-nOVA) were crossed with transgenic mice expressing an OVA-specific TCR (DO11.10). Ld-nOVA ؋ DO11.10 mice had increased numbers of CD4 
N ormal T cell repertoire contains CD4
ϩ CD25 ϩ regulatory T cells that control autoreactive immune responses in the periphery (1) (2) (3) (4) . Impairment of the generation of CD4 ϩ CD25 ϩ regulatory T cells results in various organ-specific autoimmune diseases, as demonstrated in mice thymectomized on day 3 of life (5) . It has been demonstrated that development of regulatory T cells requires the thymus (6 -8) and the presence of the relevant autoantigen in the periphery (9) . However, development of CD4 ϩ CD25 ϩ regulatory T cells remains poorly understood.
Although CD4 ϩ CD25 ϩ T cells are anergic to TCR stimulation and suppress the activation of CD4 ϩ CD25 Ϫ T cells in an Agindependent manner, it has been demonstrated that regulatory function of CD4 ϩ CD25 ϩ T cells requires their activation via TCR in vitro (10 -12) . Seddon and Mason (9) observed that peripheral autoantigen is responsible for the survival of specific regulatory T cells in vivo. These findings suggest the critical role of TCR specificity of CD4 ϩ CD25 ϩ regulatory T cells in their generation, survival, and ability to prevent autoimmunity. Recently, Jordan et al. (13) demonstrated that, in the thymus, self-reactive T cells were positively selected as CD4 ϩ CD25 ϩ regulatory T cells and were not deleted. These results suggest that positive selection of CD4 ϩ CD25 ϩ regulatory T cells requires higher avidity interactions of their TCRs with self ligands, but that the required avidity must not exceed the threshold of the deletion (14) . However, it is unclear whether avidity of autoreactive TCRs that induce positive selection as CD4 ϩ CD25 ϩ regulatory T cells is different from avidity of autoreactive TCRs that induce negative selection.
The immune system controls autoreactivity by several mechanisms such as clonal deletion and inactivation. Accumulating evidences suggest that receptor editing or revision, which is induced by autoreactive stimuli and involves endogenous TCR gene rearrangement, is also involved in the generation of nonautoreactive T cell repertoire from autoreactive T cell repertoire (15) (16) (17) . Moreover, it is suggested that secondary TCR gene rearrangement occurs to escape not only from clonal deletion, but also from death by neglect during thymic selection (18, 19) . Interestingly, disturbance of endogenous TCR gene rearrangement seems to be associated with the impaired development of regulatory T cells (20 -25) . Genetic manipulation of TCR ␣ gene, as in TCR ␣-chaindeficient (20, 23) and 2B4 TCR ␣-chain transgenic mice (22) , sometimes spontaneously induces organ-specific autoimmune diseases, such as inflammatory bowel disease, autoimmune gastritis, and thyroiditis. Itoh et al. (7) found that CD4 ϩ CD25 ϩ T cells in a TCR-transgenic model expressed endogenous TCR chains and disappeared in recombination-activating gene 2 (RAG2) 3 To examine the ontogeny of CD4 ϩ CD25 ϩ T cells, we used neo-autoantigen-bearing transgenic mice expressing chicken egg OVA systemically in the nuclei (Ld-nOVA) and transgenic mice expressing an OVA-specific TCR (DO11.10). We found that part of autoreactive T cells could be positively selected as CD4 ϩ CD25 ϩ T cells in parallel with their deletion in the thymus. We also found that endogenous TCR gene rearrangement generates autoreactive CD4 ϩ CD25 ϩ regulatory T cells from nonautoreactive T cells and nonautoreactive CD4 ϩ CD25 Ϫ T cells from autoreactive T cells.
Materials and Methods

Mice
BALB/c mice were obtained from SLC (Shizuoka, Japan). They were maintained in a temperature-and light-controlled environment with free access to food and water under specific pathogen-free conditions. Female age-matched mice were used in all experiments, and the mice were 7-10 wk old at the start of each experiment. DO11.10 transgenic mice whose T cells express a receptor specific for OVA were kindly provided by T. Watanabe (Medical Institute of Bioregulation, Kyashu University, Fukuoka, Japan). DO11.10 TCR ␣ single transgenic mice were kindly provided by S. Koyasu (Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan). RAG2-deficient BALB/c mice and TCR ␣-chain-deficient C57BL/6 mice were purchased from Taconic Farms (Germantown, NY). Generation of Ld-nOVA transgenic mice has been described in another study (26) . Briefly, chicken egg OVA cDNA (kindly provided by P. Chambon, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Universite Louis Pasteur, Strasbourg, France) fused with the nuclear localization signal at the 3Ј end was subcloned into pLG-E, which had been produced by inserting a human E enhancer into the 5Ј end of the L d class I promoter of pLG-2 plasmid (27) . This OVA transgene construct was microinjected into the pronuclei of fertilized eggs from C57BL/6 mice. Ld-nOVA BALB/c mice were produced by crossing Ld-nOVA C57BL/6 mice with normal BALB/c mice for more than eight generations. TCR ␣-chain-deficient BALB/c mice were produced by crossing TCR ␣-chaindeficient C57BL/6 mice with normal BALB/c mice for more than six generations.
Preparation of cell populations
Spleen cells were first enriched in T cells by using mouse CD3 ϩ T cell enrichment columns (R&D Systems, Minneapolis, MN). T cells were then stained with FITC anti-CD4 mAb (GK1.5; BD PharMingen, San Diego, CA) and biotin anti-CD25 mAb (7D4; BD PharMingen), followed by staining with anti-FITC microbeads. CD4 ϩ T cells were purified with MACS using a positive selection column (Miltenyi Biotec, Bergisch Gladbach, Germany). For the purification of CD4 ϩ CD25 ϩ T cells, microbeads of purified CD4
ϩ T cells were released by FITC MultiSort kit. CD4 ϩ T cells were stained with streptavidin microbeads, followed by separation with MACS using a positive selection column. The purity of CD4 ϩ CD25 ϩ T cells and CD4 ϩ CD25 Ϫ T cells was ϳ88%.
In vitro proliferation assay and with irradiated (20 Gy) syngeneic spleen cells (5 ϫ 10 4 cells/well) in the presence of anti-CD3 mAb (145-2C11) at 10 g/ml or Con A (SigmaAldrich, St. Louis, MO) at 1 g/ml for 3 days, followed by a final 6 h of culture in the presence of 1 Ci [ 3 H]TdR per well. In some experiments, anti-CTLA-4 mAb (UC10-4F10-11) (100 g/ml) was added to the culture. Cells were cultured in 96-well round-bottom plates in RPMI 1640 medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 10% heat-inactivated FCS, and 5 ϫ 10 Ϫ5 M 2-ME at 37°C, 5% CO 2 . The incorporated radioactivity was counted with a gamma scintillation counter. The proliferative response was expressed as ⌬cpm (mean cpm of the test cultures minus the mean cpm of the control cultures without Ag).
Flow cytometry
The following Abs were used for identification and phenotypic analysis of T cell populations: FITC-conjugated or biotinylated KJ1-26; FITC-conjugated or PE-conjugated anti-TCRV␤2, anti-TCRV␤6, anti-TCRV␤8, anti-TCRV␤14, anti-TCRV␣2; FITC-conjugated or biotinylated anti-TCR␤ (H57-597); FITC-conjugated anti-CD25; PE-conjugated anti-CD4; PEconjugated CD8 (all from BD PharMingen); and streptavidin-Tricolor (Caltag Laboratories, Burlingame, CA).
Results
The numbers of CD4
ϩ CD25 ϩ regulatory T cells increased in the thymus and the periphery of Ld-nOVA ϫ DO11.10 mice
To investigate immunological tolerance to a systemic nuclear autoantigen, which is perturbed in systemic autoimmune diseases, we generated Ld-nOVA transgenic mice expressing OVA systemically in nuclei. We s.c. immunized Ld-nOVA mice and nontransgenic littermates with 100 g OVA in CFA at the base of the tail and then cultured the draining lymph node cells with various doses of OVA or OVA 323-339 dominant epitope (OVAp) 10 days after the immunization. The proliferative responses were greatly reduced in the Ld-nOVA mice in comparison with nontransgenic littermates, indicating that LdnOVA mice are tolerant to OVA (26) .
To address the question as to how autoreactive T cells specific for a nuclear autoantigen were rendered tolerized, we mated LdnOVA mice with DO11.10 transgenic mice that express a TCR (V␣13.1, V␤8.2) specific for the OVAp bound to I-A d class II MHC molecules and monitored DO11.10 TCR-bearing cells using an anti-clonotypic Ab, KJ1-26.
Thymocyte numbers in Ld-nOVA ϫ DO11.10 mice were significantly reduced to ϳ55% of those in DO11.10 mice (1 ϫ 10 8 cells vs 1.8 ϫ 10 8 cells, p Ͻ 0.01) ( Table I ). In comparison with DO11.10 mice, Ld-nOVA ϫ DO11.10 mice exhibited a reduction in the percentage of CD4 single-positive (SP) (6.7 Ϯ 0.4% vs 9.7 Ϯ 0.9%, p Ͻ 0.01) (Fig. 1A ) and CD4 CD8 double-positive thymocytes (61 Ϯ 5.9% vs 69 Ϯ 5.8%, p Ͻ 0.05), and an increase in the percentage of CD8 SP (2.8 Ϯ 0.4% vs 1.5 Ϯ 0.3%, p Ͻ 0.01) and CD4 CD8 double-negative thymocytes (29.5 Ϯ 5.3% vs 19.8 Ϯ 3.5, p Ͻ 0.01). These results indicated autoreactive T cells were negatively selected in the thymus. Splenic CD4 ϩ T cell numbers in Ld-nOVA ϫ DO11.10 mice were reduced to ϳ45% of those in DO11.10 mice (1.3 ϫ 10 7 cells vs 2.9 ϫ 10 7 cells, p Ͻ 0.01) ( Table I) (Fig. 1A) . CD4 ϩ T cells from the thymus and the spleen of Ld-nOVA ϫ DO11. 10 ϩ T cells of Ld-nOVA ϫ DO11.10 mice (Fig. 1B) .
We noticed that splenic CD4 ϩ T cells, lymph node CD4 ϩ T cells, and CD4
ϩ SP thymocytes in Ld-nOVA ϫ DO11.10 mice contained a higher percentage of CD4 ϩ CD25 ϩ T cells (12.3, 18.2, and 4%, respectively) than those in DO11.10 mice (3.6, 3.3, and 1.2%, respectively) ( Table I ). Absolute numbers of CD4 ϩ CD25 ϩ T cells were also increased in Ld-nOVA ϫ DO11.10 mice. Most of clonotypic T cells in DO11.10 mice were CD4 ϩ CD25 Ϫ T cells, whereas most of clonotypic T cells in Ld-nOVA ϫ DO11.10 mice were CD4 ϩ CD25 ϩ T cells ( Fig. 2A) . We next investigated whether these CD4 ϩ CD25 ϩ T cells were regulatory T cells. CD4
ϩ CD25 ϩ T cell-depleted CD4 ϩ T cells from Ld-nOVA ϫ DO11.10 exhibited a more vigorous response to OVAp than CD4 ϩ T cells from Ld-nOVA ϫ DO11.10, although they exhibited a lower response than CD4 ϩ CD25 ϩ T cell-depleted DO11.10 CD4 ϩ T cells (Fig. 2B) . CD4 ϩ CD25 ϩ T cells from Ld-nOVA ϫ DO11.10 mice had the ability to suppress the proliferative responses of CD4 ϩ CD25 Ϫ T cells not only from the Ld-nOVA ϫ DO11.10 mice, but also from nontransgenic BALB/c mice. This inhibitory function was partially blocked by anti-CTLA-4 (Fig.  2C) . Because we did not use anti-CTLA4 Fab, the abrogation of inhibition was not so distinguished as demonstrated in the previous reports (28 -30) . These results indicate that CD4 ϩ CD25 ϩ T cells generated in Ld-nOVA ϫ DO11.10 mice are regulatory T cells. ϩ CD25 ϩ T cells (Fig. 3) . These results are consistent with T cells in Ld-nOVA ϫ DO11.10 ␣-chain mice contained a higher percentage of clonotypic T cells than CD4 ϩ CD25 Ϫ T cells in DO11.10 ␣-chain mice, as shown in Fig. 3 , cell numbers of clonotypic T cells in Ld-nOVA ϫ DO11.10 ␣-chain mice were lower than those in DO11.10 ␣-chain mice. 
T cells expressing endogenous TCR chains
CD25
Ϫ T cells were clonotype low T cells (Fig. 4A) . On the contrary, in the thymus and the spleen of DO11.10 mice, most CD4 ϩ
Ϫ T cells were clonotype high T cells, whereas CD4 ϩ
ϩ T cells were clonotype low T cells (Fig. 4A ). These clonotype low T cells in lymph nodes (Fig. 4B ) and the thymus (data not shown) expressed not only endogenous V␣s, but also endogenous ϩ CD25 ϩ T cells were prepared from four Ld-nOVA ϫ DO11.10 mice, four DO11.10 mice, and four nontransgenic BALB/c mice. CD4 ϩ CD25 Ϫ T cells were prepared from four nontransgenic BALB/c mice. In some wells, an anti-CTLA-4 mAb (100 g/ml) was added to the culture. A representative result of three independent similar experiments is shown. The proliferative response was expressed as ⌬cpm (the mean cpm of the test cultures minus the mean cpm of the control cultures without Ag). DBL, Ld-nOVA ϫ DO11.10 double-transgenic mice.
GENERATION OF AUTOREACTIVE CD4
and to the generation of CD4 ϩ CD25 ϩ T cells in DO11.10 mice suggests that endogenous TCR gene rearrangement is used not only for the avoidance of autoreactivity, but also for the generation of CD4 ϩ CD25 ϩ regulatory T cells, probably by creating autoreactive TCRs. To confirm this possibility, we generated RAG2-deficient DO11.10 mice and RAG2-deficient Ld-nOVA ϫ DO11.10 mice, in which endogenous TCR gene rearrangement was impaired. Although the numbers of CD4 ϩ T cells in spleens from RAG2-deficient Ld-nOVA ϫ DO11.10 mice were reduced by clonal deletion, most of the CD4 ϩ T cells were CD4 ϩ CD25 ϩ T cells (Fig. 5A) , supporting the idea that autoreactive T cells were selected as CD4 ϩ CD25 ϩ T cells. We confirmed that these CD4 ϩ CD25 ϩ T cells had the ability to suppress the proliferative responses of CD4 ϩ CD25 Ϫ T cells from nontransgenic BALB/c mice in vitro (Fig. 6) . On the contrary, most of CD4 ϩ T cells in spleens of RAG2-deficient DO11.10 mice were CD4 ϩ CD25 Ϫ T cells and lacked CD4 ϩ CD25 ϩ T cells. Furthermore, we generated TCR ␣-chain-deficient DO11.10 mice and TCR ␣-chain-deficient Ld-nOVA ϫ DO11.10 mice. These mice had almost the same phenotype as RAG2-deficient DO11.10 mice and RAG2-deficient Ld-nOVA ϫ DO11.10 mice, respectively (Fig. 5B) . We also confirmed the suppressive activity of CD4 ϩ CD25 ϩ T cells in TCR ␣-chain-deficient Ld-nOVA ϫ DO11.10 mice (data not shown). These results indicate that endogenous TCR expression, especially endogenous ␣-chain expression, plays an important role in the generation of regulatory T cells in DO11.10 mice.
Interestingly, although CD4 SP T cells in the thymus of RAG2-deficient Ld-nOVA ϫ DO11.10 mice contained not only CD4 ϩ CD25 ϩ T cells, but also a large population of CD4 ϩ CD25 Ϫ T cells, splenic CD4 ϩ T cells were exclusively CD4 ϩ CD25 ϩ T cells. This finding suggests that there might be another selection mechanism in the periphery that differentially acts on CD4 ϩ CD25 ϩ regulatory T cells. Taken together, these findings indicate that autoreactive T cells are selected as CD4 ϩ CD25 ϩ regulatory T cells and that endogenous TCR gene rearrangement plays a critical role in the generation of CD4 ϩ CD25 ϩ regulatory T cells from nonautoreactive T cells and in the generation of nonautoreactive T cells from autoreactive T cells.
Discussion
We found that autoreactive T cells were positively selected as CD4 ϩ
CD25
ϩ regulatory T cells in parallel with clonal deletion in the thymus. These results indicate that part of autoreactive T cells that have a high affinity TCR enough to lead to clonal deletion could be positively selected as CD4 ϩ
ϩ T cells in the thymus. We also found that endogenous TCR expression generates CD4 ϩ
ϩ regulatory T cells from the nonautoreactive T cells and nonautoreactive CD4 ϩ
Ϫ T cells from the autoreactive T cells. In Sakaguchi and coworkers' papers (7, 22) , the regulatory T cells in TCR-transgenic models were endogenous TCR ␣-chainexpressing cells, whereas, in our Ld-nOVA ϫ DO11.10 mice, the regulatory T cells did not express endogenous TCRs. However, these findings do not contradict each other. In the case of CD4 ϩ T cells expressing high affinity TCRs with peripheral autoantigens or nonself ligands, these T cells could be positively selected as CD4 ϩ CD25 Ϫ T cells without clonal deletion or endogenous TCR chain expression. Because CD4 ϩ T cells expressing TCRs specific for autoantigens in the thymus might be selected as CD4 ϩ CD25 ϩ regulatory T cells, in transgenic mice expressing a TCR specific for an exogenous Ag such as DO11.10 mice, CD4 ϩ CD25 ϩ regulatory T cells are selected only from CD4 ϩ T cells expressing endogenous TCR chains. Therefore, the impairment of endogenous TCR chain expression led to the disappearance of regulatory T cells. On the contrary, in the case of transgenic mice expressing a TCR specific for a systemic autoantigen such as Ld-nOVA ϫ DO11.10 mice, CD4 ϩ CD25 ϩ regulatory T cells are selected from CD4 ϩ T cells expressing a transgenic TCR without endogenous TCR chain expression.
Because endogenous TCR gene rearrangement occurs to escape not only negative selection (15, 16) , but also death by neglect during positive selection (18, 19) , it is suggested that endogenous TCR gene rearrangement occurs to generate T cells expressing TCRs that have appropriate affinity for a self MHC/self peptide above the selection threshold. Thus, there is a possibility that endogenous TCR gene rearrangement might play an important role in the generation of CD4 ϩ CD25 ϩ T cells from nonautoreactive T cells through creating autospecific TCRs and the generation of CD4 ϩ CD25 Ϫ T cells from autoreactive CD4 ϩ T cells. Therefore, it should be addressed whether second TCR gene rearrangement contributes to the generation of CD4 ϩ CD25 ϩ T cells and CD4 ϩ CD25 Ϫ T cells in nontransgenic mice. Our experiment revealed that CD4 ϩ CD25 ϩ T cells contain a certain T cell repertoire specific for a systemic nuclear autoantigen. Although CD4 ϩ CD25 ϩ T cells are anergic to TCR stimulation and suppress the activation of CD4 ϩ CD25 Ϫ T cells in an Ag-independent manner, it has been demonstrated that regulatory function of CD4 ϩ CD25 ϩ T cells requires their activation via TCR in vitro (10 -12) . Autoreactivity of regulatory T cells increases the chance that they encounter their stimulators in periphery. Thus, it is rational that regulatory T cells are specific for autoantigens in the thymus, which may be systemic autoantigens.
Jordan regulatory T cells and did not undergo clonal deletion in contrast to our transgenic models. The lack of deletion can probably be attributed either to a lower affinity TCR compared with our transgenic model or to the expression level of the self ligand. These findings suggest that CD4 ϩ CD25 ϩ regulatory T cells comprise a broad autoreactive T cell repertoire. Table I ). Histograms of staining with KJ1-26 were gated for CD4 
